📌 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘄 𝗶𝗻 𝗗𝗶𝗮𝗯𝗲𝘁𝗲𝘀 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 - 𝟮𝟬𝟮𝟱 𝗔𝗗𝗔 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲?

Описание: Dear Doctors,

And last but not the least, it is an honor to kindly present Dr. Cho Mar’s Insights on:

✅ “Diabetes Technology” and

✅ “Retinopathy, Neuropathy, and Foot Care”

📌 This program is organized by the Myanmar Diabetes Association (MMDA) and the Myanmar Society of Endocrinology and Metabolism (MSEM).

💊 This program is proudly supported by 𝗭𝗶𝗴𝗹𝗶𝗽 𝟱𝟬 & 𝟭𝟬𝟬 (𝗦𝗶𝘁𝗮𝗴𝗹𝗶𝗽𝘁𝗶𝗻 𝟱𝟬 𝗺𝗴 & 𝟭𝟬𝟬 𝗺𝗴) 𝗮𝗻𝗱 𝗘𝗺𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 & 𝟮𝟱 (𝗘𝗺𝗽𝗮𝗴𝗹𝗶𝗳𝗹𝗼𝘇𝗶𝗻 𝟭𝟬 𝗺𝗴 & 𝟮𝟱 𝗺𝗴).

#ADA #StandardsofCare
#ADAguideline #Recommendations
#Diabetes #Hyperglycemia
#Obesity #WeightManagement
#DiabetesTechnology #Retinopathy
#Neuropathy #FootCare
#CardiovascularDisease
#GlycemicGoals #Renal
#MSEM #MMDA
#Ziglip #Sitagliptin
#Emflozin #Empagliflozin
#MyanmarDiabetesAssociationMMDA